Papers
1
Total Citations
1
H-Index
1
About
Chao Zhi is a distinguished urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal cell carcinoma, with a particular focus on robotic-assisted procedures for complex kidney tumors. Dr. Zhi’s major contributions include pioneering the use of robotic partial nephrectomy for large, cystic renal cell carcinomas—a traditionally challenging tumor type often requiring radical nephrectomy. As a key member of the ROSULA Collaborative Group, Dr. Zhi co-authored a landmark multi-institutional analysis demonstrating the safety and efficacy of this approach for T2 cystic tumors, helping to expand nephron-sparing surgery options. This work, published in 2025, has already garnered early citations, reflecting its immediate impact on clinical practice. Dr. Zhi’s research is notable for its emphasis on collaborative, multi-center data to establish robust surgical guidelines, directly influencing how surgeons approach high-complexity kidney cancers. By pushing the boundaries of what is possible with robotic surgery, Dr. Zhi is helping to improve patient outcomes—preserving kidney function while achieving excellent oncologic control—and setting new standards in the field of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1